p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy

Overexpression of the ErbB2/HER2 receptor tyrosine kinase occurs in up to 20% of human breast cancers and correlates with aggressive disease. Several efficacious targeted therapies, including antibodies and kinase inhibitors, have been developed but the occurring of resistance to these agents is oft...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisaro, Brigitte, Sciortino, Marianna, Colombo, Shana, Leal, Maria Pilar Camacho, Costamagna, Andrea, Castellano, Isabella, Montemurro, Filippo, Rossi, Valentina, Valabrega, Giorgio, Turco, Emilia, Defilippi, Paola, Cabodi, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826217/
https://www.ncbi.nlm.nih.gov/pubmed/26716506
http://dx.doi.org/10.18632/oncotarget.6710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826217/
https://www.ncbi.nlm.nih.gov/pubmed/26716506
http://dx.doi.org/10.18632/oncotarget.6710

Ejemplares similares